Financial Life Planners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$173 Hold
7
﹤0.01% 318
2026
Q1
$198 Buy
+7
New +$186 ﹤0.01% 344
2025
Q4
Sell
-7
Closed -$174 252
2025
Q3
$174 Buy
+7
New +$173 ﹤0.01% 340
2025
Q1
Sell
-6
Closed -$146 291
2024
Q4
$146 Buy
+6
New +$163 ﹤0.01% 386

Other funds holding PFE

Financial Life Planners's PFE Position: Q2 2026 in Review

Financial Life Planners held its Pfizer (PFE) position steady in Q2 2026 at 7 shares worth $173. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Financial Life Planners first reported a position in PFE in Q4 2024 and has held it in 4 quarters since. The position peaked at $198 in Q1 2026. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Financial Life Planners held 7 shares of Pfizer worth $173 as of Q2 2026.
  • Financial Life Planners left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Financial Life Planners's portfolio in Q2 2026, its #318 holding.
  • Financial Life Planners first reported a position in Pfizer in Q4 2024 and has held it in 4 quarters since.
  • Financial Life Planners's Pfizer position peaked at $198 in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Financial Life Planners's 13F filing for Q2 2026, filed 21 Jul 2026.